Maccura Biotechnology Co.Ltd (SHE:300463)

Market Cap	7.04B
Revenue (ttm)	2.55B
Net Income (ttm)	126.81M
Shares Out	606.83M
EPS (ttm)	0.21
PE Ratio	21.93
Forward PE	23.43
Dividend	0.15 (1.33%)
Ex-Dividend Date	Jul 3, 2024

Volume	5,590,200
Average Volume	6,371,053
Open	11.40
Previous Close	11.60
Day's Range	11.40 - 11.67
52-Week Range	10.88 - 17.31
Beta	0.19
RSI	38.45
Earnings Date	Apr 22, 2025

About SHE:300463

Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of IVD products and related services in China and internationally. The company offers immunoassay products, such as chemiluminescence analyzers and reagents; clinical chemistry reagents for hepatic function, glycometabolism, iron and other, renal function, coagulation, special protein, cardiac, and lipids; and clinical laboratory products, such as automatic hematology, and automatic and semi-automatic coagulation analyzers. It provides SARS-COV-2(COVID-19) ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1994
• Employees: 3,362
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300463

Financial Performance

In 2024, SHE:300463's revenue was 2.55 billion, a decrease of -11.98% compared to the previous year's 2.90 billion. Earnings were 126.81 million, a decrease of -59.44%.